Biotronik expands peripheral portfolio with a new treatment tool for interventions in complex lesions
Ngày 11/04/2019 07:22 | Lượt xem: 172

Biotronik has presented the company’s Pulsar-18 T3 stent system for the first time during the Leipzig Interventional Course (LINC; 22–24 January, Leipzig, Germany). 

The Pulsar-18 T3 system is a unique combination of three technologies for an improved implantation procedure, a company press release states. The 4F low profile decreases the risk of access site complications and reduces the need for closure devices compared to 6F, while the tri-axial shaft design facilitates stable and accurate implantation of the clinically proven Pulsar stent. The intuitive and ergonomic wheel-operated handle simplifies handling during the procedure for physicians.

The superficial femoral artery (SFA) requires a stent that conforms to the natural vessel movement and provides sufficient support in complex and long lesions. The new device unifies proven technologies for efficient delivery of stents up to 200mm to the challenging SFA. The thin struts, low chronic outward force (COF) and high multidirectional flexibility of the Pulsar stent ensure conformability and support to the vessel in all natural vessel movements.

“Pulsar-18 T3 is a unique innovation; this is the first time physicians have access to a self-expanding stent system that combines the benefits of 4F with the accurate deployment of a tri-axial system,” stated Alexander Uhl, senior vice president of Corporate Marketing at Biotronik. “Pulsar-18 T3 represents Biotronik’s dedication to providing effective therapies which minimise burden and reduce risks to patients.”

While introducing the new features to enhance deployment, the new stent system builds on the established Pulsar-18 stent. Recent data highlighted the long term safety and efficiency of Pulsar-18 by showing a freedom from target lesion revascularisation rate of 92.4% at 24 months.

The 4F delivery system offers a number of benefits, including clinically proven lower access site complication rates and a reduced need for closure devices compared to 6F stents. With its low COF and thin struts of 140µm, Pulsar-18 is proven to cause less vessel injury and inflammation, provide faster endothelialisation and lower the risk of restenosis.

Pulsar-18 T3 is indicated for use in patients with atherosclerotic disease of the superficial femoral, proximal popliteal and infrapopliteal arteries and for the treatment of insufficient results after percutaneous transluminal angioplasty (PTA), e.g. residual stenosis and dissection.

Source VasscularNews

Duc Tin Clinic

Print Chia sẽ qua facebook bài: Biotronik expands peripheral portfolio with a new treatment tool for interventions in complex lesions Chia sẽ qua google bài: Biotronik expands peripheral portfolio with a new treatment tool for interventions in complex lesions Chia sẽ qua twitter bài: Biotronik expands peripheral portfolio with a new treatment tool for interventions in complex lesions Chia sẽ qua MySpace bài: Biotronik expands peripheral portfolio with a new treatment tool for interventions in complex lesions Chia sẽ qua LinkedIn bài: Biotronik expands peripheral portfolio with a new treatment tool for interventions in complex lesions Chia sẽ qua stumbleupon bài: Biotronik expands peripheral portfolio with a new treatment tool for interventions in complex lesions Chia sẽ qua icio bài: Biotronik expands peripheral portfolio with a new treatment tool for interventions in complex lesions Chia sẽ qua digg bài: Biotronik expands peripheral portfolio with a new treatment tool for interventions in complex lesions Chia sẽ qua yahoo bài: Biotronik expands peripheral portfolio with a new treatment tool for interventions in complex lesions Chia sẽ qua yahoo bài: Biotronik expands peripheral portfolio with a new treatment tool for interventions in complex lesions Chia sẽ qua yahoo bài: Biotronik expands peripheral portfolio with a new treatment tool for interventions in complex lesions Chia sẽ qua yahoo bài: Biotronik expands peripheral portfolio with a new treatment tool for interventions in complex lesions

Tin tức liên quan

CUSTOMER REVIEWS

  • I am Nguyen Thanh Sang, born in 1990. Since the examination and treatment at the clinic Duc Tin, I am very grateful to the Doctor for explaining and sharing about my illness. During the treatment time in the clinic I was very caring staff of the clinic. Now my illness has improved in a good way. Expect more and more clinic to be able to save many patients.

    I sincerely thank you !. Tel: 0938303275

  • Huynh Thi Muoi, born in 1940, was examined and treated at Duc Tin Clinic. I am very pleased about how to serve and care patients of the clinic. The doctor is committed to explaining and sharing with the patient.

    Huynh Thi Muoi sincerely thank you! Phone number: 0972868746

  • As I said Duc Tin surgical clinin is where my family trust, hope to visit. Physicians caring, thoughtful, gentle to the patient. Nurses and staff clinic polite, cheerful and thoughtful. This clinic clean, sterile, so I would love to. Tel: +84949914060.

  • The doctor is very caring, attentive and very gentle nurse, courteous, affable with me. The clinic is clean, comfortable, polite. I enjoyed this faith. Every visit I was very relieved disease. Tel: 0839820792.

  • I was patient, had to clinics of Dr. Le Duc Tin. I see very conscientious doctor patient care, answer any questions and very dedicated staff from the receptionist to the children tested, nursing. Clinics very clean and spacious. I'm very satisfied. Tel: +841227880829.

Search
Customer support

    Phone: (028) 3981 2678
    Mobile: 0903 839 878 - 0909 384 389

TOP